Overview
Thyroid extract is dried and powdered thyroid glands from pigs containing tiiodothyronine (T3) and thyroxine (T4) used to supplement low or absent thyroid activity. Thyroid extract has been described in literature to treat hypothyroidism since 1891 but its use dates back as far as the 6th century. Thyroid extract is no longer considered a first line therapy as it delivers a dose that is inconsistent with the stated strength of the tablet. Currently, patients are more likely to be treated with levothyroxine. Thyroid extracts were never FDA approved as their use in the United States predates the FDA.
Indication
Thyroid extract is indicated for replacement therapy in decreased or absent thyroid function.
Associated Conditions
- Hypothyroidism
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| PD-Rx Pharmaceuticals, Inc. | 43063-345 | ORAL | 30 mg in 1 1 | 9/26/2023 | |
| ANI Pharmaceuticals, Inc. | 62559-744 | ORAL | 120 mg in 1 1 | 6/15/2023 | |
| Nivagen Pharmaceuticals, Inc. | 75834-313 | ORAL | 90 mg in 1 1 | 11/2/2023 | |
| Dr. Donna Restivo DC | 62185-0059 | ORAL | 6 [hp_X] in 1 mL | 5/23/2025 | |
| Vitruvias Therapeutics | 69680-152 | ORAL | 90 mg in 1 1 | 1/5/2024 | |
| Deseret Biologicals, Inc. | 43742-0240 | ORAL | 8 [hp_X] in 1 mL | 5/27/2025 | |
| Vitruvias Therapeutics | 69680-150 | ORAL | 30 mg in 1 1 | 1/5/2024 | |
| Rebel Distributors Corp | 42254-105 | ORAL | 30 mg in 1 1 | 10/27/2010 | |
| PD-Rx Pharmaceuticals, Inc. | 55289-261 | ORAL | 60 mg in 1 1 | 9/22/2023 | |
| Nivagen Pharmaceuticals, Inc. | 75834-316 | ORAL | 240 mg in 1 1 | 11/2/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| ERFA THYROID | erfa canada 2012 inc | 02499428 | Tablet - Oral | 60 MG | N/A |
| EUGLANDIN F | dr reckeweg and co | 00245933 | Liquid - Oral | 12 X / 100 ML | 12/31/1972 |
| ERFA THYROID | erfa canada 2012 inc | 02499436 | Tablet - Oral | 125 MG | N/A |
| THYROID | searchlight pharma inc | 00023957 | Tablet - Oral | 60 MG | 12/31/1951 |
| THYROID | searchlight pharma inc | 00023965 | Tablet - Oral | 125 MG | 12/31/1951 |
| EUGLANDIN M | dr reckeweg and co | 00245925 | Liquid - Oral | 12 X / 100 ML | 12/31/1972 |
| THYROIDINUM | seroyal international inc. | 02233760 | Pellet
,
Liquid
,
Drops
,
Tablet
,
Globules
,
Granules - Oral | 6 X | 4/6/1998 |
| ERFA THYROID | erfa canada 2012 inc | 02499401 | Tablet - Oral | 30 MG | N/A |
| THYROID | searchlight pharma inc | 00023949 | Tablet - Oral | 30 MG | 12/31/1951 |
| CIMICIFUGA PLEX | seroyal international inc. | 02235035 | Liquid
,
Drops
,
Granules
,
Syrup
,
Pellet
,
Tablet - Oral | 10 X | 4/6/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.